The group’s principle activities are to manage product development programs for U.S. government agencies, and providing consulting services to companies in the biotechnology and pharmaceutical industries. The group’s product line includes vaccines and therapeutics to protect against emerging infectious diseases, biological and chemical warfare threat agents and seasonal and pandemic influenza. The group operates from United States.
